We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug & Device Products
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Publications
    • Webinar Training Pass
    • eCFR and Guidances
    • Books
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » Webinar Recordings » Medical Devices and the FDA Reauthorization Act of 2017 - Webinar Recording/Transcript

Other Options

Audio Recording/Transcript - July 26, 2018

$287.00

Audio Recording/Transcript - July 26, 2018

$258.00

Audio Recording/Transcript - July 26, 2018

$244.00

Audio Recording/Transcript - July 26, 2018

$230.00

Audio Recording/Transcript - July 26, 2018

$215.00

Medical Devices and the FDA Reauthorization Act of 2017 - Webinar Recording/Transcript

$287.00
Webinar Recordings

Product Details

Medical Devices and the FDA Reauthorization Act of 2017: What YOU Need to Know about FDARA

Many devicemakers are viewing changes in the FDA Reauthorization Act of 2017 (FDARA) as a good thing, but the devil is in the details — and some of those details start taking effect next month. It’s time you got up to speed.

FDAnews has reached out to a prominent member of the FDA Bar, Jessica Ringel Esq. of King & Spalding LLP’s Washington office, for explanations and insights.

Over 90 fast-paced minutes, Ms. Ringel will bring you current on:

  • User fees: Changes you can expect in the fees your company pays for premarket submissions
  • FDA Inspections: Improvements anticipated in the inspections process
  • Certificates to Foreign Governments: How transparency in issuance and denials will increase
  • Pediatric device development: Specific FDA efforts to stimulate innovation in this area
  • What’s to come: New guidances, rules and reports anticipated from the agency in coming years
  • And much more!

FDARA deadlines start hitting next month. Every devicemaker needs to know how the changes will cause benefit — or harm. Discover the details with one of Washington’s most knowledgeable presenters.

  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Fax 703.538.7676 – Toll free 888.838.5578

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing